Droxidopa 100mg Capsules
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, take it exactly as directed by your doctor. Carefully read all the information provided with your prescription and follow the instructions closely.
When taking your medication:
- Swallow the tablet whole.
- Do not chew, open, or crush it.
- You can take it with or without food, but be consistent in how you take it each time. Choose to either always take it with food or always take it on an empty stomach.
To minimize the risk of high blood pressure during sleep, take your last dose of the day at least 3 hours before bedtime.
Storing and Disposing of Your Medication
Keep your medication at room temperature in a dry place, avoiding storage in a bathroom. Ensure that all medications are kept in a safe location, out of the reach of children and pets, to prevent accidental ingestion.
What to Do If You Miss a Dose
If you miss a dose, skip it and continue with your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take your blood pressure regularly, especially when lying down, sitting, and standing, as directed by your doctor.
- Avoid taking your last dose too close to bedtime (at least 3 hours before) to reduce the risk of high blood pressure while lying down.
- Report any symptoms of high blood pressure (e.g., severe headache, blurred vision) or very low blood pressure (e.g., dizziness, fainting) to your doctor immediately.
- Stay hydrated as advised by your doctor.
- Avoid sudden changes in position (e.g., standing up too quickly).
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood pressure, including:
+ Severe headache
+ Dizziness
+ Passing out
+ Changes in eyesight
Signs of a urinary tract infection (UTI), such as:
+ Blood in the urine
+ Burning or pain when passing urine
+ Frequent or urgent need to urinate
+ Fever
+ Lower stomach pain
+ Pelvic pain
Weakness on one side of the body
Trouble speaking or thinking
Changes in balance
Drooping on one side of the face
Blurred eyesight
Falls
Neuroleptic malignant syndrome (NMS), a rare but potentially deadly condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking
+ Fast heartbeat
+ Abnormal heartbeat
+ Excessive sweating
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people experience no side effects or only mild ones, others may have more bothersome symptoms. If you experience any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:
Dizziness
Headache
* Upset stomach
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe headache
- Blurred vision
- Pounding in the ears
- Nosebleeds
- Chest pain
- Shortness of breath
- Confusion
- Dizziness or lightheadedness (especially when standing)
- Fainting spells
- Palpitations (feeling your heart race or pound)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you are currently taking or have recently taken any of the following medications:
+ Isocarboxazid, phenelzine, or tranylcypromine (monoamine oxidase inhibitors)
+ Linezolid or methylene blue
* If you are breastfeeding, as you should not breastfeed while taking this medication.
This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. They will help you determine if it is safe to take this medication with your existing health conditions and other medications. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Pre-existing heart conditions, such as abnormal heartbeat and heart failure, may worsen with the use of this medication. If you have a history of heart problems, discuss the potential risks with your doctor. Immediately contact your doctor if you experience any of the following symptoms: abnormal heartbeat, shortness of breath, significant weight gain, or new or worsening swelling in your arms or legs.
If you are pregnant or planning to become pregnant, consult with your doctor to discuss the potential benefits and risks associated with using this medication during pregnancy.
Overdose Information
Overdose Symptoms:
- Excessive supine hypertension
- Headache
- Palpitations
- Bradycardia (reflex)
- Cardiac arrhythmias
- Chest pain
- Nervousness
- Tremor
- Insomnia
What to Do:
Seek immediate medical attention or call a poison control center (1-800-222-1222). Treatment is supportive and symptomatic. Monitor blood pressure closely. Alpha-adrenergic blocking agents may be considered for severe hypertension.
Drug Interactions
Major Interactions
- Monoamine Oxidase Inhibitors (MAOIs): May cause hypertensive crisis due to inhibition of norepinephrine metabolism.
- Tricyclic Antidepressants (TCAs): May potentiate the pressor effect of droxidopa due to inhibition of norepinephrine reuptake.
Moderate Interactions
- Beta-adrenergic blocking agents: May antagonize the effects of droxidopa on blood pressure.
- Alpha-adrenergic agonists (e.g., phenylephrine, midodrine): May have additive pressor effects, increasing the risk of supine hypertension.
- Dopamine antagonists (e.g., metoclopramide, antipsychotics): May reduce the effectiveness of droxidopa by inhibiting its conversion to norepinephrine.
Monitoring
Baseline Monitoring
Rationale: To establish baseline BP and assess the degree of orthostatic hypotension.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline HR.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Regularly, especially during dose titration and periodically thereafter.
Target: Maintain standing BP within a safe range while avoiding excessive supine hypertension.
Action Threshold: If supine systolic BP consistently exceeds 180 mmHg, consider dose reduction or discontinuation. If supine diastolic BP consistently exceeds 110 mmHg, consider dose reduction or discontinuation.
Frequency: Regularly, especially during dose titration and periodically thereafter.
Target: Not specified, but monitor for significant changes.
Action Threshold: Significant bradycardia or tachycardia.
Symptom Monitoring
- Symptoms of orthostatic hypotension (dizziness, lightheadedness, fainting upon standing)
- Symptoms of supine hypertension (headache, blurred vision, palpitations, chest pain, shortness of breath, epistaxis, confusion)
- Symptoms of adrenergic excess (nervousness, anxiety, tremor, insomnia)
Special Patient Groups
Pregnancy
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown adverse effects at doses higher than human therapeutic doses.
Trimester-Specific Risks:
Lactation
It is not known whether droxidopa or its metabolites are excreted in human milk. Because of the potential for serious adverse reactions in breastfed infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established.
Geriatric Use
No overall differences in safety or effectiveness were observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Clinical Information
Clinical Pearls
- Droxidopa is specifically indicated for symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (e.g., Parkinson's disease, multiple system atrophy, pure autonomic failure), dopamine beta-hydroxylase deficiency, or non-diabetic autonomic neuropathy.
- The most significant adverse effect is supine hypertension; careful monitoring of blood pressure in all positions is crucial, especially during titration.
- Patients should be instructed to take the last dose at least 3 hours before bedtime to minimize the risk of supine hypertension during sleep.
- Titration should be slow and gradual (every 1-2 days) to find the lowest effective dose that manages orthostatic symptoms without causing excessive supine hypertension.
- Patients should be advised to avoid sudden position changes and to elevate the head of their bed if supine hypertension is a concern.
Alternative Therapies
- Midodrine (another alpha-1 adrenergic agonist for orthostatic hypotension)
- Fludrocortisone (mineralocorticoid for orthostatic hypotension)
- Pyridostigmine (cholinesterase inhibitor, off-label for nOH)
- Non-pharmacological interventions (e.g., increased fluid and salt intake, compression stockings, physical counter-maneuvers, head-of-bed elevation)